The stability of the genome and the genetic instability of tumors

Perspectives in Biology and Medicine

Volumn 43, Issue 2, 2000, Pages 286-300

  Strauss, Bernard S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOLOGICAL MODEL; CELL TRANSFORMATION; DNA REPAIR; DNA REPLICATION; GENETICS; HUMAN; MUTATION;

CELL TRANSFORMATION, NEOPLASTIC; DNA REPAIR; DNA REPLICATION; HUMANS; MODELS, GENETIC; MUTATION;

EID: 0034544471     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: 10.1353/pbm.2000.0010     Document Type: Article

References (85)

1. Frayn, M. Copenhagen. London: Methuen Drama, 1998.
2. Pais, A. Niels Bohr's Times: In Physics, Philosophy, and Polity. New York: Oxford UP, 1991.
3. Fisher, E. P., and Lipson, C. Thinking About Science: Max Delbruck and the Origins of Molecular Biology. New York: Norton, 1988.
4. Schrödinger, E. What Is Life? The Physical Aspect of the Living Cell. Cambridge: Cambridge UP, 1945.
5. Judson, H. F. The Eighth Day of Creation. New York: Simon & Schuster, 1979.
6. Watson, J. D. The Double Helix: A Personal Account of the Discovery of the Structure of DNA. New York: Atheneum, 1968.
7. Delbruck, M. A physicist looks at biology. Trans. Conn. Acad. Arts and Sciences 38: 173-90, 1949.
8. Wagner, R. P., and Mitchell, H. K. Genetics and Metabolism. New York: Wiley, 1955.
9. Muller, H. J., Carlson, E., and Schalet, A. Mutation by alteration of the already existing gene. Genetics 46:213-26, 1961.
10. Cohen, S. S. The synthesis of bacterial viruses in infected cells. CSH Symp. Quant. Biol. 12:35-49, 1947.
11. Chargaff, E. Voices in the labyrinth: Dialogues around the study of nature. Persp. Biol. Med. 18:251-85, 1975.
12. Schoenheimer, R. The Dynamic State of Body Constituents. Cambridge: Harvard UP, 1942.
13. Gottesman, S. Regulation by proteolysis: Developmental switches. Curr. Opin. Microbiol. 2:142-47, 1999.
14. Schwartz, A. L., and Ciechanover, A. The ubiquitin-proteasome pathway and pathogenesis of human diseases. Ann. Rev. Med. 50:57-74, 1999.
15. Judson, H. Frederick Sanger, Erwin Chargaff, and the metamorphosis of specificity. Gene 135:19-23, 1993.
16. Colvin, J. R., Smith, D. B., and Cook, W. H. The microheterogeneity of proteins. Chem. Rev. 54:687-711, 1954.
17. Ninio, J. Transient mutators: A semiquantitative analysis of the influence of translation and transcription errors on mutation rates. Genetics 129:957-62, 1991.
18. Landsteiner, K. The Specificity of Serological Reactions, rev. ed. New York: Dover, 1936.
19. Pauling, L., and Campbell, D. The manufacture of antibodies in vitro. J. Exp. Med. 76:211-20, 1942.
20. Haldane, J. B. S. The Biochemistry of Genetics. New York: Macmillan, 1954.
21. Beadle, G. W. Genes and the chemistry of the organism. In Science in Progress, 5th series, edited by G. A. Baitsell. New Haven: Yale UP, 1947. 166-96.
22. Sanger, F., and Thompson, E. Amino acid sequence in the glycyl chain of insulin. I. Identification of lower peptides from partial hydrolystaes. II. Peptides from enzymic hydrolysates. Biochem. J. 53:353-74, 1953.
23. Chargaff, E. Chemical specificity of nucleic acids and mechanism of their enzymatic degradation. Experientia 6:201-9, 1950.
24. Ingram, V. M. A specific chemical difference between the globins of normal human and sickle cell anemia hemoglobin. Nature 178:792-94, 1956.
25. Furst, S. S., Roll, P. M., and Brown, G. B. On the renewal of the purines of the desoxypentose and pentose nucleic acids. J. Biol. Chem. 183:251-66, 1950.
26. Mazia, D. Physiology of the cell nucleus. In Modern Trends in Physiology and Biochemistry, edited by E. S. G. Barron. New York: Academic Press, 1952. 77-122.
27. Auerbach, C., and Robson, J. M. Chemical production of mutations. Nature 157:302, 1946.
28. Auerbach, C., and Robson, J. M. The production of mutations by chemical substances. Proc. Roy. Soc. Edinb. 62:271-83, 1947.
29. Auerbach, C., and Robson, J. Tests of chemical substances for mutagenic action. Proc. Roy. Soc. Edinb. 62:284-91, 1947.
30. Auerbach, C. Mutagenic effects of alkylating agents. Ann. N.Y. Acad. Sci. 68: 731-49, 1958.
31. Freese, E. The difference between spontaneous and base-analogue induced mutations of phage T4. Proc. Natl. Acad. Sci. USA 45:622-63, 1959.
32. Brenner, S., Barnett, L., Crick, F., and Orgel, A. The theory of mutagenesis. J. Mol. Biol. 3:121-24, 1961.
33. Cairns, J. Mutation and cancer: The antecedents to our studies of adaptive mutation. Genetics 148:1433-40, 1998.
34. Foster, P. L. Adaptive mutation: Has the unicorn landed? Genetics 148:1453-59, 1998.
35. Rosenberg, S. M., Thulin, C., and Harris, R. S. Transient and heritable mutators in adaptive evolution in the lab and in nature. Genetics 148:1559-66, 1998.
36. Watson, J. D., and Crick, F. H. C. A structure for deoxyribose nucleic acid. Nature 171:737-38, 1953.
37. Kornberg, A., Lehman, I. R., Bessman, M. J., and Simms, E. S. Enzymic synthesis of deoxyribonucleic acid. Biochim. Biophys. Acta. 21:197-98, 1956.
38. Kelner, A. Effect of visible light on the recovery of Streptomyces griseus conidia from ultra-violet irradiation injury. Proc. Natl. Acad. Sci. USA 35:73-79, 1949.
39. Witkin, E. M. Genetics of resistance to radiation in Escherichia coli. Genetics 32: 221-48, 1947.
40. Witkin, E. M. Time, temperature, and protein synthesis: A study of ultraviolet-induced mutation in bacteria. CSH Symp. Quant. Biol. 21:123-40, 1956.
41. Doudney, C., and Haas, F. L. Mutation induction and macromolecular synthesis in bacteria. Proc. Natl. Acad. Sci. USA 45:709-22, 1959.
42. Hill, R. F. A radiation-sensitive mutant of Escherichia coli. Biochim. Biophys. Acta. 30:636-37, 1958.
43. Setlow, R. B., and Carrier, W. L. The disappearance of thymine dimers from DNA: An error-correcting mechanism. Proc. Natl. Acad. Sci. USA 51:226-31, 1964.
44. Boyce, R. P., and Howard-Flanders, P. Release of ultraviolet light-induced thymine dimers from DNA in E. coli K-12. Proc. Natl. Acad. Sci. USA 51:293-300, 1964.
45. Friedberg, E., Walker, G. C., and Siede, W. DNA Repair and Mutagenesis. Washington, DC: ASM Press, 1995.
46. Friedberg, E. Correcting the Blueprint of Life: An Historical Account of the Discovery of DNA Repair Mechanisms. Plainview, NY: Cold Spring Harbor Laboratory Press, 1997.
47. Blattner, F. R., Plunkett, G., 3rd, Bloch, C. A., et al. The complete genome sequence of Escherichia coli K-12 [comment]. Science 277:1453-74, 1997.
48. Drake, J. W., Charlesworth, B., Charlesworth, D., and Crow, J. F. Rates of spontaneous mutation. Genetics 148:1667-86, 1998.
49. Schaaper, R. M. Base selection, proofreading, and mismatch repair during DNA replication in Escherichia coli. J. Biol. Chem. 268:23762-65, 1993.
50. Strauss, B. S., Sagher, D., and Acharya, S. Role of proofreading and mismatch repair in maintaining the stability of nucelotide repeats in DNA. Nucleic Acids Res. 25:806-13, 1997.
51. LeClerc, J. E., Payne, W. L., Kupchella, E., and Cebula, T. A. Detection of mutator subpopulations in Salmonella typhimurium LT2 by reversion of his alleles. Mutat. Res. 400:89-97, 1998.
52. Bucci, C., Lavitola, A., Salvatore, P., et al. Hypermutation in pathogenic bacteria: Frequent phase variation in meningococci is a phenotypic trait of a specialized mutator biotype. Mol. Cell. 3:435-45, 1999.
53. Winter, D. B., and Gearhart, P. J. Dual enigma of somatic hypermutation of immunoglobulin variable genes: Targeting and mechanism. Immunol. Rev. 162: 89-96, 1998.
54. Storb, U., Peters, A., Klotz, E., et al. Immunoglobulin transgenes as targets for somatic hypermutation. Int. J. Dev. Biol. 42:977-82, 1998.
55. Woodruff, M. F. Tumor clonality and its biological significance. Adv. Cancer Res. 50:197-229, 1988.
56. Sidransky, D. Screening for clonal genetic alterations. Eur. J. Cancer 31A:1127-29, 1995.
57. Loeb, L. A. Cancer cells exhibit a mutator phenotype. Adv. Cancer Res. 72:25-56, 1998.
58. Tomlinson, I. P., Novelli, M. R., and Bodmer, W. F. The mutation rate and cancer. Proc. Natl. Acad. Sci. USA 93:14800-803, 1996.
59. Tomlinson, I., and Bodmer, W. Selection, the mutation rate and cancer: Ensuring that the tail does not wag the dog. Nature Med. 5:11-12, 1999.
60. Sharp, P. M., Averof, M., Lloyd, A. T., et al. DNA sequence evolution: The sounds of silence. Phil. Trans. Roy. Soc. Lond. B. 349:241-47, 1995.
61. Evan, G., and Littlewood, T. A matter of life and cell death. Science 281:1317-22, 1998.
62. Hainaut, P., Hernandez, T., Robinson, A., et al. IARC database of p53 gene mutation in human tumors and cell lines: Updated compilation, reused formats and new visualisation tools. Nucleic Acids Res. 26:205-13, 1998.
63. Strauss, B. S. Hypermutability in carcinogenesis. Genetics 148:1619-26, 1998.
64. Strauss, B. S. Hypermutability and silent mutations in human carcinogenesis. Semin. Cancer Biol. 8:431-38, 1998.
65. Hussain, S. P., and Harris, C. C. Molecular epidemiology of human cancer: Contribution of mutation spectra studies of tumor suppressor genes. Cancer Res. 58:4023-37, 1998.
66. Lauren-Puig, P., Beroud, C., and Soussi, T. APC gene: Database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res. 26:269-70, 1998.
67. Loeb, L., Springgate, C., and Battula, N. Errors in DNA replication as a basis of malignant change. Cancer Res. 34:2311-21, 1974.
68. Haselkorn, R. Developmentally regulated gene rearrangements in prokaryotes. Ann. Rev. Genet. 26:113-30, 1992.
69. Hiom, K., Melek, M., and Gellert, M. DNA transposition by the RAG1 and RAG2 proteins: A possible source of oncogenic translocations. Cell 94:463-70, 1998.
70. Pasqualucci, L., Migliazza, A., Fracchiolla, N., et al.. BCL-6 mutations in normal germinal center B cells: Evidence of somatic hypermutation acting outside Ig loci. Proc. Natl. Acad. Sci. USA 95:11816-21, 1998.
71. Shen, H. M., Peters, A., Baron, B., et al. Mutation of BCL-6 gene in normal B cells by the process of somatic hypermutation of Ig genes. Science 280:1750-52, 1998.
72. Cairns, J., Overbaugh, J., and Miller, S. The origin of mutants. Nature 335:142-45, 1988.
73. Rosche, W. A., and Foster, P. L. The role of transient hypermutators in adaptive mutation in Escherichia coli. Proc. Natl. Acad. Sci. USA 96:6862-67, 1999.
74. Strauss, B. S. The origin of point mutations in human tumor cells. Cancer Res. 52:249-53, 1992.
75. Harris, R. S., Feng, G., Ross, K. J., et al. Mismatch repair protein MutL becomes limiting during stationary-phase mutation. Genes Dev. 11:2426-37, 1997.
76. Cunningham, J. M., Christensen, E. R., Tester, D. J., et al. Hypermehtylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 58:3455-60, 1998.
77. Herman, J. G., Umar, A., Polyak, K., et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. USA 95:6870-75, 1998.
78. Johnson, R. E., Prakash, S., and Prakash, L. Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Polη. Science 283:1001-4, 1999.
79. Masutani, C., Kusumoto, R., Yamada, A., et al. The XPV (xeroderma pigmentosum variant) gene encodes DNA polymerase eta. Nature 399:700-704, 1999.
80. Nelson, J. R., Lawrence, C. W., and Hinkle, D. C. Thymine-thymine dimer bypass by yeast DNA polymerase zeta. Science 272:1646-49, 1996.
81. Gibbs, P. E., McGregor, W. G., Maher, V. M., et al. A human homolog of the Saccharomyces cervisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta. Proc. Natl. Acad. Sci. USA 95:6876-80, 1998.
82. Tang, M., Bruck, I., Eritja, R., et al. Biochemical basis of SOS-induced mutagenesis in Escherichia coli: Reconsitution of in vitro lesions bypass dependent on the UmuD′2C mutagenic complex and RecA protein. Proc. Natl. Acad. Sci. USA 95(17):9755-60, 1998.
83. Higgins, N. P., Kato, K., and Strauss, B. A model for replication repair in mammalian cells. J. Mol. Biol. 101:417-25, 1976.
84. Cordeiro-Stone, M., Makhov, A. M., Zaritskaya, L. S., and Griffith, J. D. Analysis of DNA replication forks encountering a pyrimidine dimer in the template to the leading strand. J. Mol. Biol. 289:1207-18, 1999.
85. Kane, M. F., Loda, M., Gaida, G. M., et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 57:808-11, 1997.